Seth Lederman
Chief Executive Officer, Director · Tonix Pharmaceuticals Holding Corp.
- 2026
- Aug 31, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Seth Lederman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Richard Newcomb Stillwell - $58K in TNXP purchases and sales in the last 12 months
- Carolyn E. Taylor - $15K in TNXP purchases and sales in the last 12 months
- Richard H. Bagger - $13K in TNXP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Seth Lederman?
Seth Lederman is a corporate insider, tracked as Chief Executive Officer, Director of Tonix Pharmaceuticals Holding Corp. (TNXP). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Seth Lederman submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Seth Lederman been buying or selling stock?
Recorded transactions: 4 open-market purchases ($373K) and 0 open-market sales across all tracked filings.
